Divestment30 Apr 2026, 03:36 pm
Laurus Labs Board Approves Voluntary Closure of German Subsidiary
AI Summary
Laurus Labs Ltd's Board of Directors approved the voluntary closure of Laurus Generics GmbH (Germany), a step-down wholly-owned subsidiary. The closure is subject to regulatory approvals in Germany. The company clarified that Laurus Generics GmbH is not a material subsidiary, reporting Nil turnover for the financial year ended March 31, 2026, and a negative net worth of Euro 1,053,091. The closure is not expected to have any material impact on Laurus Labs or its financial performance.
Key Highlights
- Board approved voluntary closure of Laurus Generics GmbH.
- German subsidiary is a non-material, step-down entity.
- Laurus Generics GmbH reported Nil turnover for FY26.
- Net worth of the subsidiary was negative €1.05 million.
- Closure will not materially impact company financials.
Price Impact
More from LAURUSLABS